Testing Methodology and Clinical Advantages of a Newborn Screening Protocol for Severe Combined Immunodeficiency
Abstract
Severe combined immunodeficiency (SCID) is a genetic disorder defined by a disruption in the development of functional T cells and B cells that circulate in the body (1). This immunodeficiency is the most severe form of primary immunodeficiencies, exposing its victims to extreme vulnerability to infectious diseases, resulting in the more common name “the bubble boy disease”. Due to the severity of this immunodeficiency disorder, an early diagnosis would be ideal in order to prevent infant fatally in SCID patients. Advanced screening protocols immediately after birth are crucial in providing prompt treatment to infants, determining their quality life and ultimately preventing death. This paper will discuss the etiology of SCID, the clinical presentation and diagnosis of SCID, and will proceed to highlight the advantages and disadvantages of a newborn screening protocol.
Keywords:
SCID, Newborn, ScreeningDownloads
References
Burg MVD, Gennery AR. Educational paper. European Journal of Pediatrics. 2011Sep;170(5):561–71.
Spigel S. NEWBORN SCREENING FOR PRIMARY IMMUNODEFICIENCY DISEASE [Internet]. NEWBORN SCREENING FOR PRIMARY IMMUNODEFICIENCY DISEASE. [cited 2020Mar5]. Available from: https://www.cga.ct.gov/2008/rpt/2008-R-0564.htm
Aloj G, Giardino G, Valentino L, Maio F, Gallo V, Esposito T, et al. Severe Combined Immunodeficiences: New and Old Scenarios. International Reviews of Immunology. 2012;31(1):43–65.
Puck JM. Population-based newborn screening for severe combined immunodeficiency: Steps toward implementation. Journal of Allergy and Clinical Immunology. 2007;120(4):760–8.
Gennery AR. Diagnosis of severe combined immunodeficiency. Journal of Clinical Pathology. 2001Jan;54(3):191–5.
Fleisher TA. Newborn Screening for Severe Combined Immunodeficiency in 11 Screening Programs in the United States. Pediatrics. 2015Jan;136(Supplement).
Chapel H. Classification of primary immunodeficiency diseases by the International Union of Immunological Societies (IUIS) Expert Committee on Primary Immunodeficiency 2011. Clinical & Experimental Immunology. 2012Feb;168(1):58–9.
Berneburg M. Faculty of 1000 evaluation for Efficacy of gene therapy for X-linked severe combined immunodeficiency. F1000 - Post-publication peer review of the biomedical literature. 2010;
Blackburn MR, Thompson LF. Adenosine Deaminase Deficiency: Unanticipated Benefits from the Study of a Rare Immunodeficiency. The Journal of Immunology. 2012;188(3):933–5.
Six E, Lagresle-Peyrou C, Susini S, Chappedelaine CD, Sigrist N, Sadek H, et al. AK2 deficiency compromises the mitochondrial energy metabolism required for differentiation of human neutrophil and lymphoid lineages. Cell Death & Disease. 2015; 6(8).
Niewiesk S. Maternal Antibodies: Clinical Significance, Mechanism of Interference with Immune Responses, and Possible Vaccination Strategies. Frontiers in Immunology. 2014;5.
Gennery AR. Diagnosis of severe combined immunodeficiency. Journal of Clinical Pathology. 2001Jan;54(3):191–5.
Stanford Children's Health [Internet]. Stanford Children's Health - Lucile Packard Children's Hospital Stanford. [cited 2020Mar5]. Available from: https://www.stanfordchildrens.org/en/topic/default?id=severe-combined-immunodeficiency-scid-90-P01706
Gilger M, Matson D, Conner M, Rosenblatt H, Finegold M, Estes M. Extraintestinal rotavirus infections in children with immunodeficiency. The Journal of Pediatrics. 1992;120(6):912–7.
Bittles A. Consanguinity and its relevance to clinical genetics. Clinical Genetics. 2008Jul;60(2):89–98.
Hague RA, Rassam S, Morgan G, Cant AJ. Early diagnosis of severe combined immunodeficiency syndrome. Archives of Disease in Childhood. 1994Jan;70(4):260–3.
Fogarty L. Thrush And Septic Shock In A Two-Month-Old. The Pediatric Infectious Disease Journal. 1996;15(6):553–4.
Gatti R, Meuwissen H, Allen H, Hong R, Good R. Immunological Reconstitution of Sex-Linked Lymphopenic Immunological Deficiency. The Lancet. 1968;292(7583):1366–9.
SCID Newborn Screening [Internet]. IPOPI. 2018 [cited 2020Mar5]. Available from: https://ipopi.org/scid-newborn-screening/
Fischer A. Severe combined immunodeficiencies (SCID). Clinical and Experimental Immunology. 2000;122(2):143–9.
Hershfield MS, Chaffee S, Sorensen RU. Enzyme Replacement Therapy with Polyethylene Glycol-Adenosine Deaminase in Adenosine Deaminase Deficiency: Overview and Case Reports of Three Patients, Including Two Now Receiving Gene Therapy. Pediatric Research. 1993;33.
Newborn screening for severe immunodeficiency: advantage in the case of early diagnosis and infection prophylaxis. [cited 2020Mar5]. Available from: https://www.iqwig.de/en/press/press-releases/newborn-screening-for-severe-immunodeficiency-advantage-in-the-case-of-early-diagnosis-and-infection-prophylaxis.7743.html
Chan K, Puck JM. Development of population-based newborn screening for severe combined immunodeficiency. Journal of Allergy and Clinical Immunology. 2005;115(2):391–8.
Agyemang A, Wang J. Newborn Screening for Severe Combined Immunodeficiency and T–Cell Lymphopenia in California, 2010–2017. Pediatrics. 2019;144.
Downloads
Posted
Section
Categories
License
Copyright (c) 2021 Alicia Ryan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Any non-commercial use, distribution, adaptation, and reproduction in any medium is permitted as long as the original work is properly cited. However, caution and responsibility are required when reusing as the articles on the preprint server are not peer-reviewed. Readers are advised to check for the availability of any updated or peer-reviewed version.
